...2001 Dresden, Germany $10.9M Kinaxo Biotechnologies GmbH Cellular target profiling services 2005 Martinsried, Germany $764K RNAx GmbH...

...Nucleis and RNAx will co-market shRNA target validation technology. The deal combines Nucleis' Speedy Mouse transgenic...
...Speedy Mouse transgenic animal generation technology with RNAx's shRNA constructs. Nucleis SA , Lyon, France RNAx GmbH...

...Funakoshi will exclusively market in Japan RNAx's services based on its RNAi technology for use in...
...technology for use in validating siRNA oligos and genetic targets for experimental and therapeutic use. RNAx GmbH...

...Alnylam business unit Ribopharma AG (Kulmbach, Germany) licensed to RNAx non-exclusive rights to IP covering the...
...use of short double-stranded RNAs to elicit RNAi for use in RNAx's research services business. RNAx...
...initial and annual license fees plus royalties to Ribopharma. Alnylam Pharmaceuticals Inc. , Cambridge, Mass. RNAx GmbH...

...Functional genomics company RNAx granted metaGen access to its RNA interference (RNAi) validation technology. metaGen will...
...use the technology to validate cancer gene targets, and retains the rights to all results. RNAx...
...scientists from the Max Planck Institute for Infection Biology . metaGen GmbH , Berlin, Germany RNAx GmbH...

...Functional genomics company RNAx (Berlin, Germany) granted metaGen (Berlin, Germany) access to its RNA interference (RNAi...
...use the technology to validate cancer gene targets, and retains the rights to all results. RNAx...